Fibrous bodies are associated with lower GH production and decreased expression of E-cadherin in GH-producing pituitary adenomas.
D000236:Adenoma / Q000378:metabolism* / Q000473:pathology*; D000328:Adult; D000368:Aged; D015415:Biomarkers; D001971:Bromocriptine; D015820:Cadherins / Q000032:analysis / Q000378:metabolism*; D005260:Female; D013006:Growth Hormone / Q000032:analysis / Q000378:metabolism*; D006727:Hormone Antagonists; D006801:Humans; D007150:Immunohistochemistry; D007334:Insulin-Like Growth Factor I / Q000032:analysis; D007633:Keratins / Q000032:analysis; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D010911:Pituitary Neoplasms / Q000378:metabolism* / Q000473:pathology*; D011388:Prolactin / Q000032:analysis; D012189:Retrospective Studies
D015415:Biomarkers; C400901:CAM 5.2 antigen; D015820:Cadherins; D006727:Hormone Antagonists; D001971:Bromocriptine; D007334:Insulin-Like Growth Factor I; D007633:Keratins; D011388:Prolactin; D013006:Growth Hormone